Navigation Links
Looking Towards More Effective Leukemia Treatment

Eighty percent of the time childhood acute lymphoblastic leukemia is curable with chemotherapy. The bad news is doctors are not sure // why it doesn’t work for the other 20 percent of patients. Now, new research finds it could be because of a small number of genes that are resistant to drugs used to treat the disease.

Researchers tested leukemia cells from 173 children. They looked at the sensitivity of the cells to four different treatment drugs. The cells were then assessed to identify which ones were drug-sensitive and which ones were drug-resistant. The gene-expression patterns were then compared with the original 173 patients and 98 children from another institution.

Researchers identified a number of different genes that were resistant to each of the four drugs. They found the patients with more of the resistant genes were less likely to respond to treatment. Researchers say of the 124 genes identified, 121 have not previously been associated with resistance to the four chemotherapy drugs.

Thus researchers conclude saying that a relatively small number of genes can play a role in the resistance to treatment for children with acute lymphoblastic leukemia.
'"/>




Page: 1

Related medicine news :

1. Palmist Claims to Diagnose Ailments Looking At Your Palm
2. Plastic Surgeons Looking Forward To First Full Face Transplant
3. Looking For A Friend Or Life Partner? Join A Gym
4. Researchers Looking for Genes That Control the Brain
5. Attitude Towards AIDS Patients – Time For A Change
6. Scientists Awarded Appropriately For Contribution Towards Medical Research
7. A Step Towards Unraveling The Schizophrenia And Depression Mystery
8. Are Women Not Hearty Enough Towards Seeking Heart Care?
9. RPB grants $7.9 Million Towards Research
10. Blood Transfusion May Have Contributed Towards Hepatitis C
11. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... June 20, 2017 , ... ... , is pleased to announce a new online course entitled Personal & ... practical insights and evidence-based strategies for achieving optimal well-being and teaches students how ...
(Date:6/20/2017)... ... , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief of the ... the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed publications. Among ... and Co-Chair of The Fenway Institute, a member of the US President’s Emergency ...
(Date:6/20/2017)... York, NY (PRWEB) , ... June 20, 2017 , ... ... today their continued expansion and success in the clinical trials market. Similar to its ... a track record in the clinical trials marketplace by proving the value of eVisits ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. Kejriwal ... leading-edge care, whether or not they have a referral. Dr. Kejriwal offers state-of-the-art ... laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. This ...
(Date:6/20/2017)... ... June 20, 2017 , ... ... (AHN) Jefferson Hospital is providing physicians with advanced capabilities for diagnosing and treating ... than traditional MRIs, enabling doctors to get a more accurate look inside the ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... the U.S. Food and Drug Administration (FDA) has notified the ... to its Zhejiang, China manufacturing facility ... "The successful clearance of the Warning Letter related to our ... a measure of the progress we have made in our ...
(Date:6/9/2017)... , June 9, 2017 More than ... further effort to help spread lessons learned from clinical ... International Diabetes Federation (IDF) and Eli Lilly and Company ... the second phase of the Bringing Research in Diabetes ... their commitment to helping people with diabetes effectively manage ...
(Date:6/7/2017)... , June 7, 2017  Novavax, Inc., (Nasdaq: ... of two Phase 2 trials of its RSV F protein ... child bearing age have been published in the journal ... have been shared in prior scientific conferences). The Company previously ... April 2014. Novavax is developing the RSV F Vaccine with ...
Breaking Medicine Technology: